1. Home
  2. AVNS vs DNA Comparison

AVNS vs DNA Comparison

Compare AVNS & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avanos Medical Inc.

AVNS

Avanos Medical Inc.

HOLD

Current Price

$12.29

Market Cap

521.7M

Sector

Health Care

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$9.65

Market Cap

562.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVNS
DNA
Founded
2014
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
521.7M
562.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AVNS
DNA
Price
$12.29
$9.65
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$10.50
AVG Volume (30 Days)
563.1K
950.4K
Earning Date
02-25-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$699,900,000.00
$180,606,000.00
Revenue This Year
$3.07
N/A
Revenue Next Year
$2.16
$3.07
P/E Ratio
N/A
N/A
Revenue Growth
2.70
N/A
52 Week Low
$9.30
$5.00
52 Week High
$17.69
$17.58

Technical Indicators

Market Signals
Indicator
AVNS
DNA
Relative Strength Index (RSI) 59.92 56.16
Support Level $11.38 $9.39
Resistance Level $12.41 $10.00
Average True Range (ATR) 0.43 0.50
MACD 0.07 0.14
Stochastic Oscillator 93.33 65.60

Price Performance

Historical Comparison
AVNS
DNA

About AVNS Avanos Medical Inc.

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: